BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9009235)

  • 1. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
    Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
    Lu Y; Liao QP; Chen CL; Yu L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of integrin expression in a well differentiated endometrial adenocarcinoma cell line (Ishikawa).
    Castelbaum AJ; Ying L; Somkuti SG; Sun J; Ilesanmi AO; Lessey BA
    J Clin Endocrinol Metab; 1997 Jan; 82(1):136-42. PubMed ID: 8989247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
    Farnell YZ; Ing NH
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):453-61. PubMed ID: 12732290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
    Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the progesterone receptor and estrogen receptor in decidua basalis by progesterone and estradiol during pregnancy.
    Ogle TF; Dai D; George P; Mahesh VB
    Biol Reprod; 1998 May; 58(5):1188-98. PubMed ID: 9603252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
    Tseng L; Zhu HH
    Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
    Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells.
    Prange-Kiel J; Rune GM; Zwirner M; Wallwiener D; Kiesel L
    Exp Clin Endocrinol Diabetes; 2001; 109(4):231-7. PubMed ID: 11453036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa.
    Fujimoto J; Hori M; Ichigo S; Tamaya T
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):1-8. PubMed ID: 9009232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.
    Falany JL; Falany CN
    Endocrinology; 1996 Apr; 137(4):1395-401. PubMed ID: 8625916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
    Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
    Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
    Chu Y; Wang Y; Zhang G; Chen H; Dowdy SC; Xiong Y; Liu F; Zhang R; Li J; Jiang SW
    Cell Mol Life Sci; 2014 Sep; 71(17):3393-408. PubMed ID: 24531693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
    Horvath G; Leser G; Helou K; Henriksson M
    Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.
    Bramlett KS; Burris TP
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):27-34. PubMed ID: 12943742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
    Di Simone N; Schneyer AL; Caliandro D; Castellani R; Caruso A
    Mol Cell Endocrinol; 2002 Jun; 192(1-2):187-95. PubMed ID: 12088879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.